Silencing of KRT19 potently induces senescence program in NSCLC cells and boosts anti-PD-1 immunotherapy efficiency by potentiating stronger antineoplastic responses of tumor-infiltrating cytotoxic CD8+ T cells. Here, CD8A is linked to neoplasm.